Results 271 to 280 of about 332,110 (380)

ABSTRACTS

Precision Radiation Oncology, EarlyView.
wiley   +1 more source

Explanation strategies in humans versus current explainable artificial intelligence: Insights from image classification

British Journal of Psychology, EarlyView.
Abstract Explainable AI (XAI) methods provide explanations of AI models, but our understanding of how they compare with human explanations remains limited. Here, we examined human participants' attention strategies when classifying images and when explaining how they classified the images through eye‐tracking and compared their attention strategies ...
Ruoxi Qi, Yueyuan Zheng, Yi Yang, Caleb Chen Cao, Janet H. Hsiao   +4 more
wiley   +1 more source

Spatial Variation in Cd, Pb, Hg, and Zn Accumulation in Edible Wild-Growing Mushroom Species from Different Environmentally Loaded Areas in Southern Poland: Risk Assessment and Implications for Consumer Safety. [PDF]

Toxics
Rusin M, Domagalska J, Czendlik A, Wróbel N, Kidoń A.   +4 more
europepmc   +1 more source

The Australia story: Current status and future challenges for the clinical applications of psychedelics

British Journal of Pharmacology, EarlyView.
Abstract The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4‐methylenedioxymethamphetamine (MDMA), which have revealed great potential for treating mental health conditions. Given this progress in research, as well as the current unmet clinical need of millions of patients, in 2023, the Australian Therapeutic ...
David J Nutt, Peter Hunt, Anne Katrin Schlag, Paul Fitzgerald   +3 more
wiley   +1 more source

The mushroom matrix: an engineered mycelium-derived biochar platform for advanced biotechnological applications. [PDF]

Front Bioeng Biotechnol
Tian X, Du TY, Lu W, Kumla J, Tarafder E, Priyadarshani TDC, Perera RH, Hapuarachchi KK, Suwannarach N.   +8 more
europepmc   +1 more source

Contents of free amino acids in mushrooms.

, 1985
Eri Sato, Yasuo Aoyagi, Tatsuyuki Sugahara   +2 more
openalex   +2 more sources

Psilocybin as a novel treatment for chronic pain

British Journal of Pharmacology, EarlyView.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey, Reena Lasrado, Maria Maiarú, Gary J. Stephens   +3 more
wiley   +1 more source

Arginine Delays Postharvest Softening of Button Mushroom (<i>Agaricus bisporus</i>) via Lipid Metabolism Regulation. [PDF]

Foods
Xu D, Gao L, Mu X, Wang T, Liang J, Wang Q, Niu Q.   +6 more
europepmc   +1 more source

Epidemiological and clinical characteristics of severe poisonous mushroom poisoning in children in Yunnan Province: A retrospective analysis of 23 cases from 2020 to 2022

Zhen Tian, Yang Li, Cheng Guo, Kai Liu, Juan Xie   +4 more
openalex   +1 more source

Psychedelics, entactogens and psychoplastogens for depression and related disorders

British Journal of Pharmacology, EarlyView.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley   +1 more source